Guardian Health  a recent new issue came public on 10/4/18 during a tough market environment but yet the stock has acted well. Guardant makes noninvasive blood-based cancer diagnostics tests based on proprietary technology. “The Guardant Health IPO priced 12.5 million shares at 19. That was above its estimated range of 15 to 17. Shares opened at 27.75 for an initial gain of 46%”. You can read more about HERE.

Industry Group is the medical services group, ranked number 17 out of 197 groups. is not making money yet, but the sales have been impressive in the last four quarters; +217%, +96%, +90%, +95%.


is down 3-days in a row to its 10 and 20 day moving averages, I have an interest on the long side if and only if it can get thru yesterday’s high (37.87). This is my plan; buy stop 37.97, stop-loss 37, target up.



Trade Like A Pro With the Most Powerful Stock Research Platform;

This information is issued solely for informational and educational purposes and does not constitute an offer to sell or a solicitation of an offer to buy securities. None of the information contained in this blog constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. From time to time, the content creator or its affiliates may hold positions or other interests in securities mentioned in this blog. The stocks presented are not to be considered a recommendation to buy any stock. This material does not take into account your particular investment objectives. Investors should consult their own financial or investment adviser before trading or acting upon any information provided. Past performance is not indicative of future results.